Urogenital Tract Infection

The Korean Association of Urogenital Tract Infection and Inflammation (대한요로생식기감염학회)
권호 표지
DOI QR코드

DOI QR Code

Moving towards Evidence-Based Clinical Practice Guidelines

  • Jung, Jae Hung (Department of Urology, Yonsei University Wonju College of Medicine) ;
  • Franco, Juan VA (Argentine Cochrane Centre, Instituto Universitario Hospital Italiano) ;
  • Dahm, Philipp (Urology Section, Minneapolis Veterans Healthcare System)
  • Received : 2018.10.04
  • Accepted : 2018.12.04
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

The Institute of Medicine in its report "Clinical Practice Guidelines we can trust" defined standards for clinical practice guidelines. However, many guidelines continue to rely on expert opinion and lack a formal framework for moving from evidence to recommendations. These guidelines may or may not be labeled as "consensus statements" and do not meet contemporary standards for guideline documents we would refer to as "evidence-based". Therefore, the Grading of Recommendations Assessment, Development and Evaluation working group developed a novel, rigorous and transparent approach to grading certainty (quality) of evidence. In addition, it created a system for "moving from evidence to decisions", for example for the development of evidence-based guidelines. In this article, we aim to introduce this approach to appraising the certainty of relevant evidence and estimate the benefits and detriments of health care interventions within the larger context of evidence-based medicine.

Keywords

References

  1. Korea Centers for Disease Control. Guidelines for the antibiotic use in urinary tract infections [Internet]. Cheongju: Korea Centers for Disease Control; 2018 [cited 2018 Sep 24]. Available from: http://www.cdc.go.kr/CDC/together/CdcKrTogether0302.jsp?menuIds=HOME006-MNU2804-MNU3027-MNU2979&cid=138017.
  2. Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med 2016;21:125-7. https://doi.org/10.1136/ebmed-2016-110401
  3. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ; GRADE Working Group. What is "quality of evidence" and why is it important to clinicians? BMJ 2008;336:995-8. https://doi.org/10.1136/bmj.39490.551019.BE
  4. Zimerman AL. Evidence-based medicine: a short history of a modern medical movement. Virtual Mentor 2013;15:71-6.
  5. Guyatt GH. Evidence-based medicine. ACP J Club 1991;114:A16.
  6. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. 1996. Clin Orthop Relat Res 2007;455:3-5.
  7. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992;268:2420-5. https://doi.org/10.1001/jama.1992.03490170092032
  8. Sackett DL, Strauss SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: how to practice and teach EBM. 2nd ed. Edinburgh: Churchill Livingstone; 2000.
  9. Robin Graham; Institute of Medicine. Clinical practice guidelines we can trust. Washington, DC: National Academies Press; 2011.
  10. Siering U, Eikermann M, Hausner E, Hoffmann-Esser W, Neugebauer EA. Appraisal tools for clinical practice guidelines: a systematic review. PLoS One 2013;8:e82915. https://doi.org/10.1371/journal.pone.0082915
  11. Ioannidis JP. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q 2016;94:485-514. https://doi.org/10.1111/1468-0009.12210
  12. Higgins JPT, Lasserson T, Chandler J, Tovey D, Churchill R. Methodological Expectations of Cochrane Intervention Reviews [Internet]. London: Cochrane; 2018 [cited 2018 Sep 24]. Available from: https://community.cochrane.org/mecirmanual/introduction-key-points.
  13. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017;358:j4008.
  14. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. https://doi.org/10.1136/bmj.b2535
  15. Whiting P, Savovic J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol 2016;69:225-34. https://doi.org/10.1016/j.jclinepi.2015.06.005
  16. Han JL, Gandhi S, Bockoven CG, Narayan VM, Dahm P. The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality. BJU Int 2017;119:638-49. https://doi.org/10.1111/bju.13653
  17. Guyatt G, Meade M. What is evidence-based medicine? In: Guyatt G, Rennie D, Meade M, Cook D, editors. Users' guides to the medical literature. Essentials of evidence-based clinical practice. 3rd ed. New York: McGraw-Hill education; 2015. p. 16-8.
  18. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. https://doi.org/10.1136/bmj.39489.470347.AD
  19. Alonso-Coello P, Schunemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction. BMJ 2016;353:i2016.
  20. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011;64:380-2. https://doi.org/10.1016/j.jclinepi.2010.09.011
  21. Guyatt G, Eikelboom JW, Akl EA, Crowther M, Gutterman D, Kahn SR, et al. A guide to GRADE guidelines for the readers of JTH. J Thromb Haemost 2013;11:1603-8. https://doi.org/10.1111/jth.12320
  22. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al.; GRADE Working Group. Going from evidence to recommendations. BMJ 2008;336:1049-51. https://doi.org/10.1136/bmj.39493.646875.AE
  23. Schunemann HJ, Mustafa R, Brozek J, Santesso N, Alonso-Coello P, Guyatt G, et al.; GRADE Working Group. GRADE guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. J Clin Epidemiol 2016;76:89-98. https://doi.org/10.1016/j.jclinepi.2016.01.032
  24. McCormack J, Elwyn G. Shared decision is the only outcome that matters when it comes to evaluating evidence-based practice. BMJ Evid Based Med 2018;23:137-9. https://doi.org/10.1136/bmjebm-2018-110922
  25. Tikkinen KAO, Dahm P, Lytvyn L, Heen AF, Vernooij RWM, Siemieniuk RAC, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline. BMJ 2018;362:k3581.
  26. Vernooij RWM, Lytvyn L, Pardo-Hernandez H, Albarqouni L, Canelo-Aybar C, Campbell K, et al. Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review. BMJ Open 2018;8:e025470. https://doi.org/10.1136/bmjopen-2018-025470

Cited by

  1. Introduction to the GRADE Approach for Evidence-Based Clinical Practice Guideline Development vol.14, pp.1, 2018, https://doi.org/10.14777/uti.2019.14.1.26
  2. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis vol.62, pp.5, 2021, https://doi.org/10.4111/icu.20210254
  3. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review vol.30, pp.suppl4, 2021, https://doi.org/10.12968/jowc.2021.30.sup4.s42